TYRA
Tyra Biosciences Inc
NASDAQ: TYRA · HEALTHCARE · BIOTECHNOLOGY
$21.75
+1.07% today
Updated 2026-10-28
Market cap
$1.27B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.39
Dividend yield
—
52W range
$13 – $41
Volume
0.9M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.0
Quality
A3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
4.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$47.45
+118.16%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 4.45 — safe zone
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-31.14M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-51.72M | $-69.13M | $-86.48M | $-119.95M | $-45.56M |
| EPS | — | — | — | — | $-2.39 |
| Free cash flow | $-50.84M | $-50.91M | $-70.44M | $-95.28M | $-31.14M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Tyra Biosciences Inc trades at $21.75. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 4.45, it sits in the safe zone.
Frequently asked questions
What is Tyra Biosciences Inc's stock price?
Tyra Biosciences Inc (TYRA) trades at $21.75.
Is Tyra Biosciences Inc overvalued?
Tyra Biosciences Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Tyra Biosciences Inc (TYRA)?
The 12-month analyst consensus target is $47.45, about 118.2% above the current $21.75. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Tyra Biosciences Inc's Altman Z-Score is 4.45, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-33.83%
Beta0.75
50D MA$23.68
200D MA$30.25
Shares out0.07B
Float0.03B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—